ETON Eton Pharmaceuticals Earnings and EPS analysis

Relative Growth: Rel. Growth: 98

Relative Strength: Rel. Strength: 98

Relative Valuation: Rel. Valuation: 29

Relative Profitability: Rel. Profitability: 97

EPS in 2026 (TTM): $0.47

Last Report Period Date: Jun 30, 2026

As of September 2026, ETON's current EPS stands at $0.47, according to the latest financial reports. Eton Pharmaceuticals's EPS for 2025 amounted to -$0.17, marking a drop from -$0.15 in 2024. ETON reported an EPS of $0.42 for the quarterly report ending on Jun 30, 2026.

ETON earnings history

Historical annual and quarterly earnings per share (EPS) data for Eton Pharmaceuticals

EPS (TTM)

$0.47

EPS Growth YoY (Quarterly)

520%

EPS (Quarterly)

$0.42

EPS Growth (Quarterly)

600%

For 2025, Eton Pharmaceuticals's EPS was -$0.17, a drop of 13.3% from -$0.15 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $0.42, indicating a 520% increase from the same quarter last year. ETON's 12-month EPS stands at $0.47 as of June 2026. Eton Pharmaceuticals's annual EPS in 2024 stood at -$0.15, a 275% decrease year-over-year.

ETON EPS vs price chart

ETON EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

520%

EPS growth YoY

-13.3%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

During the last 12 months, Eton Pharmaceuticals has seen an EPS growth of 520% (YoY, quarterly).

ETON Earnings Waterfall

Breakdown of revenue, profit and net income for Eton Pharmaceuticals

ETON Earnings vs Peers

What are the earnings of ETON compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
ETON Eton Pharmaceuticals Inc	118.32	-13.3%	N/A	N/A
OPK Opko Health Inc	N/A	-275%	N/A	N/A
ORGO Organogenesis Holdings Inc	N/A	1,700%	10.1%	0%

All data is based on quarterly TTM periods, unless otherwise specified.